47th Annual Southeastern Wisconsin Cancer Conference: Selected Updates in Genitourinary

Milwaukee, WI US
March 21, 2015
The options for diagnosing, treating and managing cancer are constantly evolving. The primary care provider is an essential partner in the diagnosis and management of cancer. This conference is designed to present new developments in the diagnosis and treatment of genitourinary cancers by experts in their respective fields. Physicians, nurses and other allied healthcare professionals will be presented with a review of recent data of the epidemiology, screening, diagnosis, staging and multimodality, evidence- based management of genitourinary cancer.
ACCME Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Medical College of Wisconsin and Wheaton Franciscan Healthcare. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this Live Activity for a maximum of 3.25 AMA PRA Category 1 Credit(s) ™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 3.25 hours of participation for continuing education for allied health professionals.
In accordance with the Americans with Disabilities Act, the Southeastern Wisconsin Cancer Conference seeks to make this conference accessible to all. If you have a disability, which might require special accommodations, please email your needs to: info@wicancerconference.org or call (262) 523-5547.

Target Audience

  • Physicians
  • Physician Assistants
  • Nurses
  • Nurse Practitioners
  • Pharmacists
  • Pharmacy Technicians
  • Allied Health Professionals

Learning Objectives

At the conclusion of this activity, I will be able to:

  1. Determine current recommendations for prostate cancer screening in general public and high risk populations.
  2. Identify safe and effective strategies that complement standard oncology care to manage treatment or disease related adverse events         
  3. Determine  best practice in the treatment of bladder, prostate, kidney and testicular cancer
Additional information


Mary Kissinger
Phone Number: 
+1 (414) 649-7250
Course summary
Available credit: 
  • 3.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.25 Hours of Participation
    Hours of Participation credit.
Course opens: 
Course expires: 
Event starts: 
03/21/2015 - 8:00am CDT
Event ends: 
03/21/2015 - 12:00pm CDT
Italian Community Center
631 E. Chicago Street
Milwaukee, WI 53202
United States
Italian Community Center
631 E. Chicago Street
Milwaukee, WI 53202-5916




SEWCC Program Planning Committee
Paul Ritch, MD - Chairman
Teri Vega-Stromberg, MSN - Vice Chairman
Gerald Kallas, MD - Treasurer
Mary Kissinger, RHIA, CTR - Secretary
Deanna M. Birling, MSN, ANP-B AONP
Charles Bomzer, MD
Joseph Bovi, MD
Beth Brunner, ACS
Lynn Czaplewski, MS, RN
B.J. Gruling, RPh
Gerald Hanson, MD
Julie Jensen, RN, MSN, C-ANP
Thomas Jensen, MD
Kirk Ludwig, MD
Lisa Robinson, RHIA, CTR
Laura Raftery, MD
Carrie Ricconbono, MSN, RN, ACNS-BC, OCN
Paul Ritch, MD
Derek Raghavan, MD
Nicholas Vogelzang, MD
Walter Stadler, MD
Lawrence Einhorn, MD
Mark Moyad, MD
All persons in control of content have NO relevant financial relationships to disclosure except the following:



Role With Company


Mark Moyad, MD

AbbVie, Max Int’l, Farr Labs

Speaker, Consulting

Nicholas Vogelzang, MD

Janssen Biotech, Caris Life Sciences, US Oncology, DAVAOncology, Mannkind, UpToDate, Abbvie, Bavarian Nordic, Endocyte, GlaxoSmith Kline, Genentech, Celgene, Dendreon, Novartis, Pfizer, Bayer/Onyx, Exelixis

Employment, Consulting, Speaker,

Walter Stadler, MD

Bayer, Caremark/CVS, Genentech, Johnson&Johnson, MedPacto, Merck, Millenium, Sotio

Consultant/Advisory Board

Derek Raghavan, MD


Advisory Board

Lawrence Einhorn, MD

Amgen, Biogenidec


In accordance with the ACCME®  Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships.  These relationships were reviewed via the MCW conflict of interest resolution process and resolved.

Available Credit

  • 3.25 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 3.25 Hours of Participation
    Hours of Participation credit.


Please login or register to take this course.